R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma

The benefit of radiotherapy (RT) after chemotherapy in limited-stage diffuse large B-cell lymphoma (DLBCL) remains controversial. We conducted a randomized trial in patients with nonbulky limited-stage DLBCL to evaluate the benefit of RT after rituximab plus cyclophosphamide, doxorubicin, vincristin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Lamy, Thierry, Damaj, Gandhi, Soubeyran, Pierre, Gyan, Emmanuel, Cartron, Guillaume, Bouabdallah, Krimo, Gressin, Rémy, Cornillon, Jérôme, Banos, Anne, Le Du, Katell, Benchalal, Mohamed, Moles, Marie-Pierre, Le Gouill, Steven, Fleury, Joel, Godmer, Pascal, Maisonneuve, Hervé, Deconinck, Eric, Houot, Roch, Laribi, Kamel, Marolleau, Jean Pierre, Tournilhac, Olivier, Branger, Bernard, Devillers, Anne, Vuillez, Jean Philippe, Fest, Thierry, Colombat, Philippe, Costes, Valérie, Szablewski, Vanessa, Béné, Marie C., Delwail, Vincent
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757680/
https://ncbi.nlm.nih.gov/pubmed/29061568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-07-793984
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados